Current perspectives of sickle cell disease in Nigeria: changing the narratives
- 25 June 2019
- journal article
- review article
- Published by Informa UK Limited in Expert Review of Hematology
- Vol. 12 (8), 609-620
- https://doi.org/10.1080/17474086.2019.1631155
Abstract
Introduction: Sickle cell disease (SCD) is an inherited blood disorder characterized by clinical heterogeneity that may be influenced by environmental factors, ethnicity, race, social and economic factors as well as genetic and epigenetic factors. Areas covered: The present review was carried out to provide a comprehensive assessment of the current burden of SCD and treatments available for persons with SCD in Nigeria with the aim of identifying surveillance and treatment gaps, informing to guide the planning and implementation of better crisis prevention measures for SCD patients and set an agenda for new areas of SCD research in the country. This review assessed medical, biomedical and genetic studies on SCD patients in Nigeria and other endemic countries of the world. Expert opinion: Integration of hydroxyurea therapy into the management of SCD and surveillance via new-born screening (NBS) for early detection and management will improve survival of persons with SCD in Nigeria. However, it will be important to carry out pilot studies, initiate strategic advocacy initiatives to educate the people about NBS benefits, develop collaborations between potential stakeholders and design sustainable financing scheme.Keywords
This publication has 106 references indexed in Scilit:
- Global Burden of Sickle Cell Anaemia in Children under Five, 2010–2050: Modelling Based on Demographics, Excess Mortality, and InterventionsPLoS Medicine, 2013
- Hematopoietic stem-cell transplantation for sickle cell disease: current evidence and opinionsTherapeutic Advances in Hematology, 2013
- Role of oxidative stress in the pathogenesis of sickle cell diseaseIUBMB Life, 2011
- Fetal hemoglobin in sickle cell anemiaBlood, 2011
- Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG)The Lancet, 2011
- Global distribution of the sickle cell gene and geographical confirmation of the malaria hypothesisNature Communications, 2010
- Improved survival of children and adolescents with sickle cell diseaseBlood, 2010
- Prevalence and risk factors for pulmonary artery systolic hypertension among sickle cell disease patients in NigeriaAmerican Journal of Hematology, 2008
- Sickle cell disease: old discoveries, new concepts, and future promiseJCI Insight, 2007
- Deconstructing sickle cell disease: Reappraisal of the role of hemolysis in the development of clinical subphenotypesBlood Reviews, 2007